Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

YM 12617

Known as: YM-12617 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
  • N A Blaylock, Vincent G Wilson
  • British journal of pharmacology
  • 1995
  • Corpus ID: 24771666
1. The aim of this study was to examine the pharmacological characteristics of alpha-adrenoceptor-mediated contractions in two… Expand
Is this relevant?
1992
1992
1. Effects of the individual optical isomers of YM-12617 (R, S 5-[2-[[2-(o-ethoxyphenoxy)ethyl]-amino]propyl]-2… Expand
Is this relevant?
1989
1989
Recently, it has been demonstrated that two distinct alpha 1-adrenoceptor binding sites showing high and low affinity for WB-4101… Expand
Is this relevant?
1988
1988
1. Electrical and mechanical properties of smooth muscle cells of the rabbit prostate capsule and the actions of the alpha 1… Expand
Is this relevant?
1987
1987
SummaryYM-12617, 5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide HCl is structurally novel, an… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
1987
1987
Alpha-1 adrenoceptors in hypertrophied prostates of humans were characterized by a binding assay using [3H]prazosin as a… Expand
Is this relevant?
1986
1986
The alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 (5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]- 2… Expand
Is this relevant?
1986
1986
Optical isomers of YM-12617, a potent and selective alpha 1-adrenoceptor blocker, were tested on the rabbit iris dilator and… Expand
Is this relevant?
1985
1985
YM-12617, 5-[2-[[2-(2-ethoxyphenoxy)ethyl]-amino]propyl]-2 -methoxybenzenesulfonamide HCl is a structurally new type of extremely… Expand
Is this relevant?
1985
1985
SummaryYM-12617, 5-[2-[[2-(2-ethoxyphenoxy)ethyl]-amino]propyl]-2-methoxybenzenesulfonamide HCl is a structurally new type of… Expand
  • figure 2
  • table 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?